 co
market close ere preannounc guidanc ithdraw alszimm biomet ell
us cover
smith nephew biogx biomedom coverag barclay research inform compani
provid inform purpos invest recommend barclay research
zimmer biomet surpris neg pre-announce ithdraw al guidanc think market ill like
similar reaction given similar announc smith nephew sn/ ln cover ithdraw al guidanc
maintain equal weight rate think recoveri could take longer occur particularli extent
higher rate unemploy like signific earn cash flow impact busi addit
commentari
announc low er result ithdrew guidanc read-thru boston scientif johnson
johnson competitor believ market look compani like
product mix larg neurolog product stroke larg immun news underscor view
definit elect non-urg context like much broader market may
believ context orri near-term impact med-tech compani could greater market may
lastli announc even schedul earn call thursday may mean
quarter safe guidanc year ok think mayb signal quarter perhap ok dont
think necessarili say much full year view bd number put take across portfolio
past eek number emerg use approv diagnost test squar aw ay ith fda path
hospit obtain medic necess alari pump posit guidanc impli sale pump ever hile bd
expos term elect procedur compani immun either dont forget fx rate us
dollar strengthen also impact bd bottom line maintain equal weight addit
commentari
alway feel free reach ore com entari
zimmer biomet equal eight pre-announce sale note expect sale constant
currenc basi report basi midpoint dow report ould put sale million
versu bloomberg consensu estim million manag also ithdrew guidanc hich issu
take quarter miss ithdraw al guidanc surpris us given exposur elect procedur
compani sale almost entir elect ith except trauma fear across board med-tech
ow ing govern hospit suspend elect procedur respons moreov competitor smith nephew
sn/ ln cover alreadi pre-announce expect eaker result ithdrew respect full year
march smith nephew pre-announce neg result pull guidanc smith nephew sn/ ln
cover orthoped sport med ound manag compani thu bit diversifi zimmer biomet term
product mix smith nephew expect underli revenu dow expect dow substanti
march announc withdraw guidanc quantifi impact
manag state unabl estim overal impact note could materi
zb
zb announc take number effort reaction contain cost support liquid posit includ
modul manufactur output reduc variabl cost discretionari spend reduc compens leadership team
presid ceo bryan hanson forego salari zb note million cash hand decemb
unsecur multicurr revolv facil billion ith outstand borrow ing april also
note repaid billion note due april ith recent complet debt offer
zb schedul call may
zb support healthcar profession fight includ donat ppe partner ith industri coalit
use print technolog produc critic compon ventil face shield provid monetari donat
take stock hile view cost cut help believ sale reduct impact like
meaning impact earn also cash flow compani also believ return defer procedur
remain question given believ qualiti life elect procedur may priorit later extent
unemploy remain elev and/or hospit financi constrain outlook orthoped procedur and/or purchas
orthoped robot equip may reduc post-covid environ hat ere think onset year
thu maintain equal weight rate
zimmer biomet sale product
zimmer biomet sale geographi
us cover
announc preliminari revenu result market close expect revenu rang
million bloomberg consensu estim million note compani long histori beat
consensu ith past four quarter come averag consensu
manag note procedur consid high acuiti postpon hile other
use elect procedur physician may consid postpon
manag note began observ notabl neg impact busi trend march due due
rapidli evolv environ continu uncertainti ithdraw ing guidanc compani note predict
specif extent durat impact note impact could signific short term compani
chart illustr sale geograph mix
neuro includ product includ thrombectomi embol access neurosurg tool rehabilit tool
use treat condit brain includ ischem stroke brain aneurysm hemorrhag stroke condit
vascular includ thrombectomi embol product use treat diseas occur outsid brain
venou thromboembol peripher arteri occlus arterioven graft fistula de-clot peripher embol
sale product
sale geographi
read-thru johnson johnson medtron competitor
read-thru portion peripher intervent busi hich sale relev
cerenov busi hich smaller part intervent busi percent total sale trivial
mostli read-through part brain therapi busi sale neurovascular
busi hich part neurotechnolog franchis sale
today announc even schedul earn call thursday may
mean quarter safe guidanc year ok view bd number put take across
product could help
bd assay biogx privat cover announc fda grant emerg use author
biogx molecular test ill run bd molecular diagnost platform use hundr
laboratori major hich hospit nearli everi state across us accord bd bd system
process sampl simultan analyz hundr sampl per day result avail three hour
compani expect capac test per eek nationw ide announc cdc-base
test ill reimburs per test hile non-cdc test ill reimburs see link medicar
administr contractor test price hcpc code dont know specif econom bd believ
increment posit
serolog test march bd biomedom privat cover announc releas new point-of-car serolog
test detect antibodi blood confirm past current exposur littl minut ill also
avail emerg use author reimburs serolog test around competitor plan
price test around ould imagin price test somew around rang ell sinc
biomedom manufactur clear hat econom bd note kstew ithdraw
guidanc latest poc test antibodi
potenti bd test note continu ork develop antigen test point-of-
potenti product use effort bd ill also see number potenti boost relat
higher demand univers viral transport sw ab vial prepackag kit sw ab-bas specimen
collect portfolio alcohol sw ab infus set alari infus pump system abl get certif medic necess
sell/ship pump hospit need particularli hot spotsw hich plu guidanc
assum medic necess vascular access injection-rel product bd system relat reagent point-of-car
test rule flu
oil resin compon use bd product oil price remain low turn lead reduct medic grade
resin hich therefor lead reduc cog albeit time
elect procedur believ elect exposur notabl intervent busi hich includ legaci
bard busi unit -- peripher intervent surgeri lesser extent urolog critic
er hospit censu gener due elect hich impact medic deliveri solut
er lab test volum quest diagnost cover meehan us lifesci tool diagnost announc
seen signific declin lab test volum latter part march due declin physician offic visit ell
elect procedur declin like impact bd preanalyt busi sale ell diagnost system
sale
extent compani govern cut back budget off-set spend due could impact
spend bioscienc sale
extent continu eigh hospit profit could impact longer term hospit capit
equip plan impact illing upgrad infus pump ithin medic manag solut sale
us dollar strengthen impact bd sale ep outcom given geograph mix
sale product
sale geographi
net/net hile bd impact compani across med-tech believ immun either
said absent announc make us believ quarter like ok expect revis
full year result maintain equal eight
case miss last week expert call replay detail
miss call last week chief oper offic kaiser permanent san jose santa cruz california
dont fret provid replay inform discuss institut deal ith elect urgent surgeri
medic suppli devic product need ventil ppe chang bed capacity/configur
purchas bed creat icu room also discuss may influenc thought
invest servic line robot system capit equip invest upgrad comment
project may get defer revenu gener ould like still proceed
click titl access note
believ great read healthcar physician survey reduc offic visit procedur across
multipl specialti barclay global healthcar survey physician state across differ
manag urolog gastroenterolog endocrinolog dermatolog neurolog hemo-oncolog rheumatolog evalu
impact practic trend particularli offic volum elect procedur prescript pattern nearli
physician report signific declin patient offic visit averag visit around primari
reason behind declin appear patient cancel visit telehealth appoint significantli perhap
enough off-set declin in-person visit major physician indic facil hospit asc
offices/surgi-cent implement polici cancel elect procedur led signific reduct
surgeri report list common elect procedur specialti cancel usual suspect like knee
hip replac arthroscopi radiofrequ ablat nerv block spinal fusion stent etc ere list
think list greater might think includ procedur like valv replac tavr laa prevent icd
pacemak cabg peripher intervent endoscopi prostatectomi db also talk
implic med-tech
 medic suppli devic put take isrg-get readi arn flag insid
reportw review med-tech takeaw ay barclay global healthcar confer discuss american
colleg surgeon surgeon gener recommend cancel elect procedur review state health system
hospit taken action limit elect procedur action relev medic devic includ
commentari regard build new bed review hat elect procedur discuss product mix
compani review hat product could use effort compani manufactur product
feedback kol call ednesday march barclay equiti research global healthcar team
host expert confer call ith senior epidemiologist dr arnold monto md note summar takeaw ay
kstew updat trump invok dpa vent ork sign contract /mdt other
 hite hous updat on-going ant pass-along one quick updat start eekend
trump note invok defens product act ventil ork ith sever manufactur includ
hillrom view new posit compani reiter overw eight rate
kstew updat sunday rundow fda issu guidanc doc ventil focu vent edit
give run-dow eekend new provid run-dow ventil provid review fda guidanc
document issu eekend list major manufactur ventil suppli
kstew updat emerg use author confer call replay detail
biogx privat cover announc fda grant emerg use author biogx molecular test ill
run bd bd like see put take ith bd like see number potenti boost
relat product diagnost test sw ab infus sets/pump other may see offset impact
delay elect procedur
updat kstew updat prelim sale mitig plan join vent ppe maintain ow
announc preliminari result cost mitig effort disclos ork develop ventil altern
produc face shield
kstew updat post-clos ithdraw al guidanc remind expert call et
market close cover cover ithdrew
guidanc cite discuss herein read-through coverag univers
kstew read-thru follow -up poc antibodi test add anoth compani list
guidanc ithdraw al one littl interest case cover hich
competitor patient monitor space also provid updat announc
point care serolog test
kstew ithdraw guidanc latest poc test antibodi expert call edit
kstew updat review ithdraw guidanc biomedom privat announc new
point-of-car rapid serolog antibodi test upcom expert call
kstew updat select lead vaccin candid rapidli scale manufactur goal dose
morn announc progress vaccin front ith number new develop continu rate
share overw eight continu believ rel safe market ith balanc portfolio strong balanc
sheet dividend
kstew updat ithdraw guidanc cite anoth ithdraw al guidanc
unfortun think expect maintain overw eight
kstew updat sn preannounc pull id sage smoke evacu
coupl updat aw ake monday smith nephew preannouncement/guid pull id test
gain eua lot air time eekend sage continu highlight smoke evacu hen procedur filter
viru
kstew updat submit point-of-car test min less turnaround hite hous
updat vice presid mike penc announc submit point-of-car test
fda test ould abl return result minut less new new abbott discuss
 continu rate overw eight
kstew updat elect updat read-thru thought morn
md cover ithdrew prior first quarter preliminari full year outlook due impact elect
procedur believ provid read-thru med-tech sector provid physician servic ith
physician state puerto rico includ list hich state implement execut order
relat elect procedur expect med-tech compani make similar announc reiter overw eight
rate
kstew updat ny curv heighten apex could day aw ay vent bed updat new
york governor cuomo host et updat believ relev mdt-overw eight hillrom hrc-
overw eight cuomo note despit effort curv heighten comment noth slow ing spread
enough said apex could come next day said believ bed
current cuomo comment greatest need ventil
kstew updat cfo saccaro test posit ceo almeida neg viru hit
home med-tech ith baxter disclos via market close cfo jay saccaro test posit
continu perform duti albeit home isol along ith baxter home-bas employe ceo almeida
test neg undisclos member baxter board director also test posit recov ell
kstew updat extrapol icu technolog packag donat focu bed reiter ow
 reiter overw eight rate hillrom believ market appreci med-tech
capital-expenditure believ ell-posit ith portfolio today ivc-not cover
provid busi updat note see increas demand bed hich lt care bed hich believ
bode ell bed outlook
kstew updat sunday rundow fda issu guidanc doc ventil focu vent edit
give run-dow eekend new provid run-dow ventil provid review fda guidanc
document issu eekend list major manufactur ventil suppli
kstew updat ithdraw guidanc day sage recommend smoke evacu covid-
 ithdrew full year guidanc updat guidanc march
quickli thing evolv ith stick ith overw eight rate despit morn new last
night societi american gastrointestin endoscop surgeon sage recommend use filter hich
sell hen procedur reduc risk transmiss hich may repres opportun
kstew updat hillrom announc addit donat ny execut order cuomo bed ventil
updat focus tw thing hillrom donat product applic ell ny execut
order ith gov cuomo comment bed vent
kstew updat coloplast guidanc cut elect procedur read-thru updat review
coloplast guidanc cut ith read-thru medic suppli devic compani univers
updat includ firsthand insights/perspect emerg room visit new limit elect procedur
announc doubl capac manufactur suppli ventil abbott announc receiv fda
emerg use author launch test detect replay info global healthcar
kstew updat edit nh postpon elect surgeri month much
rundow latest new relev med-tech sector relat remind barclay expert
call today et gmt nh postpon elect surgeri month interest medic journal read
kstew updat ac updat guidanc triag non-emerg surgic procedur beyond
note sever updat today american colleg surgeon post on-line updat non-emerg
procedur net net updat guidanc chang overal view risk ahead elect procedur
 state hospit kaiser permanent issu recommend cancel elect procedur
like come hospit state payor plan continu react friday american colleg surgeon
saturday surgeon gener recommend canceling/postpon non-essenti elect procedur expect mani
keep come
kstew med-tech ac surgeon gener advic eekend cancel elect surgeri set ave
hospit politician action view med-tech sector like come pressur monday ow ing
american colleg surgeon updat recommend issu friday cancel elect procedur surgeon
gener comment saturday follow recommend cancel elect procedur
kristen stew art cfa herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens
 ill directli indirectli relat specif recommend view express research report
barclay capit inc and/or one affili seek busi ith compani cover research report
result investor aw firm may conflict interest could affect object report investor
consid report singl factor make invest decis
barclay research produc invest bank barclay bank plc affili collect individu
barclay author contribut research report research analyst unless otherw ise indic public date
top report reflect local time report produc may differ releas date provid gmt
avail disclosur
